Jay Steingrub to Recombinant Proteins
This is a "connection" page, showing publications Jay Steingrub has written about Recombinant Proteins.
Connection Strength
0.461
-
Steingrub JS. Steroids and drotrecogin alfa (activated) for severe sepsis. Chest. 2003 Nov; 124(5):2033.
Score: 0.185
-
Morris PE, Steingrub JS, Huang BY, Tang S, Liu PM, Rhode PR, Wong HC. A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndrome. BMC Pulm Med. 2012 Feb 16; 12:5.
Score: 0.082
-
Steingrub JS, Cheatham ML, Woodward B, Wang HT, Effron MB. A prospective, observational study of Xigris Use in the United States (XEUS). J Crit Care. 2010 Dec; 25(4):660.e9-16.
Score: 0.076
-
Levy H, Small D, Heiselman DE, Riker R, Steingrub J, Chen R, Qualy RL, Darstein C, Mongan E. Obesity does not alter the pharmacokinetics of drotrecogin alfa (activated) in severe sepsis. Ann Pharmacother. 2005 Feb; 39(2):262-7.
Score: 0.050
-
Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001 Mar 08; 344(10):699-709.
Score: 0.039
-
Wheeler A, Steingrub J, Schmidt GA, Sanchez P, Jacobi J, Linde-Zwirble W, Bates B, Qualy RL, Woodward B, Zeckel M. A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: comparison with a controlled clinical trial. Crit Care Med. 2008 Jan; 36(1):14-23.
Score: 0.015
-
Higgins TL, Steingrub JS, Tereso GJ, Tidswell MA, McGee WT. Drotrecogin alfa (activated) in sepsis: initial experience with patient selection, cost, and clinical outcomes. J Intensive Care Med. 2005 Nov-Dec; 20(6):339-45.
Score: 0.013